
Keywords: ارزیابی فارماکولوژیک; Antipsychotic; 1-(Biphenyl-4-yl)-2-[4-(substituted phenyl)-piperazin-1-yl]ethanones; Pharmacological evaluation; QSAR; Descriptor based similarity study; QSAR; quantitative structure activity relationship; EPS; extrapyramidal symptoms; GPCR; G-protein cou